Akoya Biosciences Inc (NASDAQ:AKYA) price on Thursday, July 03, rose 0.74% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.36.
A look at the stock’s price movement, the close in the last trading session was $1.35, moving within a range at $1.35 and $1.395. The beta value (5-Year monthly) was 1.352. Turning to its 52-week performance, $3.42 and $0.93 were the 52-week high and 52-week low respectively. Overall, AKYA moved 19.30% over the past month.
Akoya Biosciences Inc’s market cap currently stands at around $67.94 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AKYA is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend AKYA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AKYA’s current price about 7.26% and 11.83% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 58.37, while 7-day volatility ratio is 6.83% and 7.01% in the 30-day chart. Further, Akoya Biosciences Inc (AKYA) has a beta value of 1.36. Analysts have given the company’s stock an average 52-week price target of $2.4, forecast between a low of $2.4 and high of $2.4. Looking at the price targets, the low is -76.47% off current price level while to achieve the yearly target high, price needs to move -76.47%. Nonetheless, investors will most likely welcome a -76.47% jump to $2.4 which is the analysts’ median price.
If we refocus on Akoya Biosciences Inc (NASDAQ:AKYA), historical trading data shows that trading volumes averaged 0.71 over the past 10 days and 557.92K over the past 3 months. The company’s latest data on shares outstanding shows there are 49.84 million shares.
The 58.32% of Akoya Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 24.53% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.64 million on 2025-06-13, giving us a short ratio of 2.64. The data shows that as of 2025-06-13 short interest in Akoya Biosciences Inc (AKYA) stood at 872.0000000000001 of shares outstanding, with shares short rising to 2.4 million registered in 2025-05-15. Current price change has pushed the stock -38.46% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AKYA stock continues to rise going into the next quarter.